The government is inviting UK companies to apply for funding to develop tests that will identify patients at risk of either suffering an adverse response or not responding to specific therapies. The Technology Strategy Board in partnership with Department of Health (www.dh.gov.uk) will invest up to £7.5 million through the award of development contracts.  Selection will [...]